Stockreport

Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update [Yahoo! Finance]

Lifecore Biomedical, Inc.  (LFCR) 
PDF Lifecore Biomedical, Inc. -- Recorded Fourth Quarter Revenues of $35.7 Million and Transition Period Revenues of Million -- -- Multiple New Programs Signed in Fourt [Read more]